153 related articles for article (PubMed ID: 16510570)
21. HMGA1 is a novel transcriptional regulator of the FoxO1 gene.
Arcidiacono B; Chiefari E; Messineo S; Bilotta FL; Pastore I; Corigliano DM; Foti DP; Brunetti A
Endocrine; 2018 Apr; 60(1):56-64. PubMed ID: 29052178
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional control of the human high mobility group A1 gene: basal and oncogenic Ras-regulated expression.
Cleynen I; Huysmans C; Sasazuki T; Shirasawa S; Van de Ven W; Peeters K
Cancer Res; 2007 May; 67(10):4620-9. PubMed ID: 17510387
[TBL] [Abstract][Full Text] [Related]
23. Regulation of microRNA expression by HMGA1 proteins.
De Martino I; Visone R; Fedele M; Petrocca F; Palmieri D; Martinez Hoyos J; Forzati F; Croce CM; Fusco A
Oncogene; 2009 Mar; 28(11):1432-42. PubMed ID: 19169275
[TBL] [Abstract][Full Text] [Related]
24. The high mobility group A1 gene: transforming inflammatory signals into cancer?
Resar LM
Cancer Res; 2010 Jan; 70(2):436-9. PubMed ID: 20068164
[TBL] [Abstract][Full Text] [Related]
25. The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1.
Massimi I; Guerrieri F; Petroni M; Veschi V; Truffa S; Screpanti I; Frati L; Levrero M; Gulino A; Giannini G
Mol Carcinog; 2013 Jul; 52(7):526-34. PubMed ID: 22389255
[TBL] [Abstract][Full Text] [Related]
26. The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.
Hillion J; Roy S; Heydarian M; Cope L; Xian L; Koo M; Luo LZ; Kellyn K; Ronnett BM; Huso T; Armstrong D; Reddy K; Huso DL; Resar LMS
Gynecol Oncol; 2016 Jun; 141(3):580-587. PubMed ID: 27001612
[TBL] [Abstract][Full Text] [Related]
27. High-mobility group A1 protein: a new coregulator of peroxisome proliferator-activated receptor-γ-mediated transrepression in the vasculature.
Bloch M; Prock A; Paonessa F; Benz V; Bähr IN; Herbst L; Witt H; Kappert K; Spranger J; Stawowy P; Unger T; Fusco A; Sedding D; Brunetti A; Foryst-Ludwig A; Kintscher U
Circ Res; 2012 Feb; 110(3):394-405. PubMed ID: 22207709
[TBL] [Abstract][Full Text] [Related]
28. HMGA1 and MMP-11 Are Overexpressed in Human Non-melanoma Skin Cancer.
Greco M; Arcidiacono B; Chiefari E; Vitagliano T; Ciriaco AG; Brunetti FS; Cuda G; Brunetti A
Anticancer Res; 2018 Feb; 38(2):771-778. PubMed ID: 29374701
[TBL] [Abstract][Full Text] [Related]
29. The
De Martino M; Esposito F; Fusco A
Cell Cycle; 2020 Nov; 19(22):2955-2959. PubMed ID: 33043837
[TBL] [Abstract][Full Text] [Related]
30. Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells.
Kim DK; Seo EJ; Choi EJ; Lee SI; Kwon YW; Jang IH; Kim SC; Kim KH; Suh DS; Seong-Jang K; Lee SC; Kim JH
Exp Mol Med; 2016 Aug; 48(8):e255. PubMed ID: 27561949
[TBL] [Abstract][Full Text] [Related]
31. Dominant-negative HMGA1 blocks mu enhancer activation through a novel mechanism.
Andreucci A; Reeves R; McCarthy KM; Nikolajczyk BS
Biochem Biophys Res Commun; 2002 Mar; 292(2):427-33. PubMed ID: 11906180
[TBL] [Abstract][Full Text] [Related]
32. High-mobility group A1 proteins regulate p53-mediated transcription of Bcl-2 gene.
Esposito F; Tornincasa M; Chieffi P; De Martino I; Pierantoni GM; Fusco A
Cancer Res; 2010 Jul; 70(13):5379-88. PubMed ID: 20530667
[TBL] [Abstract][Full Text] [Related]
33. KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity.
Teng K; Wei S; Zhang C; Chen J; Chen J; Xiao K; Liu J; Dai M; Guan X; Yun J; Xie D
J Exp Clin Cancer Res; 2019 Jul; 38(1):329. PubMed ID: 31340839
[TBL] [Abstract][Full Text] [Related]
34. Interaction of adriamycin with a promoter region of hmga1 and its inhibitory effect on HMGA1 expression in A431 human squamous carcinoma cell line.
Akhter MZ; Sharma A; Rajeswari MR
Mol Biosyst; 2011 Apr; 7(4):1336-46. PubMed ID: 21336378
[TBL] [Abstract][Full Text] [Related]
35. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
[TBL] [Abstract][Full Text] [Related]
36. HMGA2, but not HMGA1, is overexpressed in human larynx carcinomas.
Palumbo A; De Martino M; Esposito F; Fraggetta F; Neto PN; Valverde Fernandes P; Santos IC; Dias FL; Nasciutti LE; Meireles Da Costa N; Fusco A; Ribeiro Pinto LF
Histopathology; 2018 Jun; 72(7):1102-1114. PubMed ID: 29266325
[TBL] [Abstract][Full Text] [Related]
37. Dynamic mitochondrial localization of nuclear transcription factor HMGA1.
Dement GA; Treff NR; Magnuson NS; Franceschi V; Reeves R
Exp Cell Res; 2005 Jul; 307(2):388-401. PubMed ID: 15893306
[TBL] [Abstract][Full Text] [Related]
38. The association between S100A13 and HMGA1 in the modulation of thyroid cancer proliferation and invasion.
Zhong J; Liu C; Chen YJ; Zhang QH; Yang J; Kang X; Chen SR; Wen GB; Zu XY; Cao RX
J Transl Med; 2016 Mar; 14():80. PubMed ID: 27008379
[TBL] [Abstract][Full Text] [Related]
39. High mobility group protein AT-hook 1 (HMGA1) is associated with the development of androgen independence in prostate cancer cells.
Takeuchi I; Takaha N; Nakamura T; Hongo F; Mikami K; Kamoi K; Okihara K; Kawauchi A; Miki T
Prostate; 2012 Jul; 72(10):1124-32. PubMed ID: 22213442
[TBL] [Abstract][Full Text] [Related]
40. High-mobility group AT-hook 1 promotes cardiac dysfunction in diabetic cardiomyopathy via autophagy inhibition.
Wu QQ; Liu C; Cai Z; Xie Q; Hu T; Duan M; Wu H; Yuan Y; Tang Q
Cell Death Dis; 2020 Mar; 11(3):160. PubMed ID: 32123163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
